PACAP 6-38Cat No. 3236 |
Price and Availability |
Biological Activity
Potent and competitive pituitary adenylate cyclase-activating polypeptide receptor (PAC)1 antagonist (IC50 = 2nM). Inhibits PACAP(1-27)-induced stimulation of adenylate cyclase (Ki = 1.5nM). Antitumor activity in vivo.Technical Data
M.Wt:(Modifications: Lys-33 = C-terminal amide)
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Certificate of Analysis / MSDS
References
Robberecht et al (1992) Structural requirements for the occupancy of pituitary adenylate-cyclase-activating-peptide (PACAP) receptors and adenylate cyclase activation in human neuroblastoma NB-OK-1 cell membranes. Discovery of PACAP(6-38) as a potent antagonist. Eur.J.Biochem. 207 239. Leyton et al (1998) PACAP(6-38) inhibits growth of prostate cancer cells. Cancer Lett. 125 131. Kojro et al (2006) The neuropeptide PACAP promotes α-secretase pathway for processing Alzheimer amyloid precursor protein. FASEB J. 20 512.If you know of a useful citation for this product please let us know.
Keywords: PACAP 6-38, Potent, PAC1, receptors, antagonists, Pituitary, Adenylate, Cyclase, Activating, Peptide, PACAP, PACAP6-38
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
Selective B2 antagonist; analog of HOE 140 (Cat.No. 3014).
ATC 0065Potent and selective MCH1 antagonist
Neuropeptide Y (scrambled)Control peptide for NPY (Cat. No. 1173).
AC 264613PAR2 receptor agonist
Kisspeptin 234KISS1/GPR54 antagonist; kisspeptin 10 analog
SF 11NPY Y2 receptor antagonist
ATC 0175 hydrochlorideMCH1 antagonist; also 5-HT2B antagonist and partial antagonist of 5-HT1A
LU AA33810Potent NPY Y5 antagonist
FPR A14FPR agonist
NPY 5RA972Potent and selective NPY Y5 antagonist
MCH (human, mouse, rat)Potent endogenous MCH agonist
2009-10 Catalog
Our range of over 3,000 life science reagents represents a unique collection of novel and exclusive research tools. Request a copy or view PDF today.




